Back
Helmerich & Payne 10K Form
Sell
38
HP
Helmerich & Payne
Last Price:
34.30
Seasonality Move:
8.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-24 | 10Q | HP/Helmerich & Payne Quarterly |
2024-01-29 | 10Q | HP/Helmerich & Payne Quarterly |
2023-11-08 | 10K | HP/Helmerich & Payne Annual |
2023-07-26 | 10Q | HP/Helmerich & Payne Quarterly |
2023-04-26 | 10Q | HP/Helmerich & Payne Quarterly |
2023-01-30 | 10Q | HP/Helmerich & Payne Quarterly |
Receive HP News And Ratings
See the #1 stock for the next 7 days that we like better than HP
HP Financial Statistics
Sales & Book Value
Annual Sales: | $2.76B |
---|---|
Cash Flow: | $62.78M |
Price / Cash Flow: | 17.59 |
Annual Sales: | $29.54 |
Price / Book: | 1.14 |
Profitability
EPS (TTM): | 3.41000 |
---|---|
Net Income (TTM): | $344.17M |
Gross Margin: | $729.04M |
Return on Equity: | 12.2% |
Return on Assets: | 7.32% |
Helmerich & Payne Earnings Forecast
Key Helmerich & Payne Financial Ratios
- The Gross Profit Margin over the past 41 years for HP is 26.45%.
- The Selling, General & Administrative Expenses for HP have been equal to 8.88% of Gross Profit Margin.
- The Research & Development expenses have been 1.49% of Revenue.
- The Interest Expense is 8.45% of Operating Income.
- The Net Earning history of HP is 12.49% of Total Revenues.
- Per Share Earnings over the last 41 years have been positive in 20 years.
Helmerich & Payne Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Energy Equipment & Services |
Sector: | Energy |
Current Symbol: | HP |
CUSIP: | 423452 |
Website: | helmerichpayne.com |
Debt
Debt-to-Equity Ratio: | 0.61 |
---|---|
Current Ratio: | 2.67 |
Quick Ratio: | 2.1 |
Price-to-Earnings
Trailing P/E Ratio: | 9.81 |
---|---|
Forward P/E Ratio: | 8.99 |
HP Technical Analysis vs Fundamental Analysis
Sell
38
Helmerich & Payne (HP)
is a Sell
Is Helmerich & Payne a Buy or a Sell?
-
Helmerich & Payne stock is rated a Sell
The current Helmerich & Payne [HP] share price is $33.73. The Score for HP is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.